Boehringer Ingelheim (Boehringer Ingelheim Ireland Limited)

Lobbying Organisation Boehringer Ingelheim

Date published 17 Sep, 2026

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May. 2026 to 31 Aug. 2026

Specific Details Email to extend an invitation to be involved in a cross-sector roundtable discussion regarding how best to support the implementation of CKD in the CDM programme in the HSE

Intended results Involvement in a cross-sector roundtable discussion regarding how to best support the implementation of CKD in the CDM programme in the HSE

Name of person primarily responsible for lobbying on this activity Linda Maher

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Email (2-5)

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Colm Burke TD (Dáil Éireann, the Oireachtas)